FDA Requires Warning for Guillain-Barré Syndrome in Prescribing Information for RSV Vaccines
Despite these concerns, experts have emphasized that the benefits of RSV vaccination outweigh potential risks for older adults, who are at heightened risk of severe RSV-related illness.